Hexima Ltd (HXL)
20mins delayed
Movement
1 Year Return
Hexima Ltd Chart
Share price | |
Last | |
Change | |
Volume | |
Turnover | |
Market Cap | $19.86 million |
Today's Movement | |
Prev. Close | |
Open | |
Day Range | - |
VWAP |
Historical Stats | |
52w Range | - |
4w Avg Volume | |
4w Avg Turnover | |
(delayed) |
HXL Statistics
15 January
1,764 / 2,260
ASX Size Rank
1yr Return
vs Sector (1yr)
-27.02%
vs ASX 200 (1yr)
-10.75%
$19.86 million
Market Cap
Share Issue
120.37 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
15 January
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Hexima Limited (HXL) is a biotechnology company actively engaged in the research and development of plant-derived defensin peptides for applications as human therapeutics. Its lead product candidate, HXP124 applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). Hexima is currently conducting a 132 patient Australian phase IIb clinical trial of HXP124 for onychomycosis.

Upcoming Calendar
Dividend History
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
No dividends paid in the last 5 years |
See Upcoming Dividends for all ASX companies.
Announcements
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Announcements provided by

Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
HXL is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
Director Transactions
HXL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code HXL in our database.
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
Name | Shares | Capital |
---|---|---|
Dato Lim Sen Yap | 14,715,790 | 11.25% |
Caroline House Superannuation Fund Pty Ltd (Caroline House S/F A/C) | 8,287,131 | 6.33% |
Woobinda Nominees Pty Ltd (The Woobinda Family A/C) | 6,372,222 | 4.87% |
Beta Gamma Pty Ltd (Walsh Street Super Fund A/C) | 5,736,586 | 4.38% |
Gowing Bros Limited | 4,256,176 | 3.25% |
Paul Orlin | 3,750,000 | 2.87% |
Gowing Bros Ltd | 3,667,131 | 2.80% |
HSBC Custody Nominees (Australia) Limited | 3,496,219 | 2.67% |
Balmoral Financial Investments Pty Ltd | 3,051,090 | 2.33% |
Adrienne Clarke | 3,028,938 | 2.31% |
Hugh Morgan | 2,977,252 | 2.28% |
Dalit Pty Ltd (Dalit Family A/C) | 2,500,000 | 1.91% |
Dongrisha Pty Ltd (The Dongrisha Investment A/C) | 2,500,000 | 1.91% |
Huysmans Pty Ltd (The Lama A/C) | 2,346,011 | 1.79% |
Marilyn Anderson | 2,280,548 | 1.74% |
Saxum Pty Ltd | 2,106,755 | 1.61% |
Cranley Nominees Pty Ltd (Fitzroy Family A/C) | 2,007,674 | 1.53% |
Pioneer Hi-Bred International Inc. | 2,000,000 | 1.53% |
Andama Holdings Pty Ltd (J & M Barlow Pension A/C) | 1,851,057 | 1.41% |
Mr Leon Francis Lachal & Mrs Susan Margaret Lachal (The Lachal Super Fund A/C) | 1,779,249 | 1.36% |
All other shareholders | 39.87 % |
The Top 20 Shareholders of HXL hold 60.13% of shares on issue.
HXL Share Price History
Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
HXL Historical Data
Download up to 20 years of share price history.
Year | Closing Price (30 June) | Last Trade |
---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Research and development of plant-derived proteins and peptides for applications as human therapeutics.
Incorporated: --
Level 4, LIMS2, Plenty Rd
Melbourne VIC 3086

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.